Navigation Links
Medivation Completes Enrollment in Confirmatory, Pivotal Phase 3 'CONNECTION' Trial of Dimebon in Patients With Alzheimer's Disease
Date:6/11/2009

About Dimebon

Dimebon is an investigational compound currently in Phase 3 development for the treatment of Alzheimer's disease and in clinical development for Huntington disease. In preclinical models of Alzheimer's disease and Huntington disease explored thus far, dimebon has been shown to inhibit brain cell death, potentially by stabilizing and improving mitochondrial function in a way that prevents neuron death and dysfunction. The dimebon mechanism is thought to be distinct from that of currently available Alzheimer's disease medications.

In addition to CONNECTION, dimebon is being studied in the 12-month Phase 3 CONCERT trial, which is evaluating the efficacy of dimebon when added to ongoing treatment with donepezil (Aricept(R)) in patients with mild-to-moderate Alzheimer's disease, and in a Phase 3 safety study. Two Phase 3 studies in moderate-to-severe Alzheimer's disease are also planned to start this year.

In Huntington disease, a Phase 2 study has been completed. Medivation and Pfizer expect to initiate a Phase 3 trial this year to evaluate the potential benefits of dimebon on cognition in patients with Huntington disease.

About Alzheimer's Disease

Alzheimer's disease is a progressive degenerative brain disorder that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate and carry out daily activities. As the disease progresses, patients may experience changes in personality and behavior, such as anxiety, suspiciousness or agitation, as well as delusions or hallucinations.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers.
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Medivation Announces Pricing of Public Offering
2. Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009
3. Medivation Announces Upcoming Scientific Presentations at Medical Conferences
4. Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update
5. Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
6. Medivation Presents New Data on Dimebons Novel Mechanism of Action
7. Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference
8. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
9. Medivation Announces Third Quarter 2008 Teleconference and Webcast on November 10, 2008
10. Medivation Announces Expiration of Hart-Scott-Rodino Waiting Period for Collaboration With Pfizer
11. Medivation Announces Presentation of 24-Week Clinical Data of MDV3100 in Castration-Resistant Prostate Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , COPENHAGEN, Nov. 19 Dan... Inbicon cellulosic ethanol plant in Kalundborg, D... one of the world,s first and largest 2nd generati... Accellerase enzymes are used in the plant,s innov...or, a Division of Danisco, was the first to market...
(Date:11/19/2009)..., , BETHESDA, Md., Nov. 19 /PRNewswire-Fir...an innovator in biotechnology for diabetes therapy...lting services to food, supplement, biotechnology ...results of Tuesday,s Annual Meeting of Shareholder...ncorporated (Nasdaq: SPEX ) elected the following...
(Date:11/19/2009)..., World,s Top Gene Synthe...nsortium (IGSC) to Coordinate Best Practices in Ri... Percent of Worldwide Gene Synthesis Capacity , ...- Five of the world’s leading gene synthesis...l apply a common screening protocol to promote bio...
(Date:11/18/2009)..., , Security personnel need to be able to find ...ontact with them. To aid such searches, the Nation...ith support from the Department of Homeland Securi...al, Standard Reference Material (SRM) 2905, Trace ...laboratory assay methods, the SRM will be helpful ...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4New NIST trace explosives standard slated for homeland security duty 2
..., Oct. 10 OPKO Health Inc. (Amex: OPK ),today an...ights for,ophthalmic uses to a topical clinical st...nt of dry eye. "Dry eye is an increasingly common...licted. It can cause significant discomfort and in... Sam Reich, Executive Vice President,of Ophthalmol...
... SAN FRANCISCO, Calif., Oct. 10 Monogram,Bioscien...fred G.,Merriweather, Senior Vice President and Ch...orporate overview at the JMP Securities Healthcare... a.m. (Eastern Time) at,the Four Seasons Hotel in ...roadcast or the subsequent archived,recording, log...
...M, Mass., Oct. 10 Microtest has announced the,ava...ting for Biological,Products: Partnering With a Co..., there is risk of virus,contamination at many lev...ination risk means virus testing is required. A pr...ological product achieves the fastest,time to mark...
Other Biology Technology:OPKO Health Acquires Rights to Clinical Stage Compound for Dry Eye 2OPKO Health Acquires Rights to Clinical Stage Compound for Dry Eye 3Monogram Biosciences to Present at the JMP Securities Healthcare Conference 2Microtest Offers Free White Paper: 'Virus Testing for Biological Products: Partnering With a Contract Lab' 2
(Date:11/22/2009)...g South Korean scientists have succeeded in produc...h bioengineering, rather than through the use of f...search, which may now allow for the production of ...n two papers in the journal Biotechnology and Bio...y. , Polymers are molecules found in everyday l...
(Date:11/22/2009)...d gene deletion can increase the likelihood of imm...ation, an international team of researchers report...re Genetics . When the gene, called UGT2B17, is mi...ecipient,s, transplants have a significantly great...rsus-host disease, in which immune cells from the ...
(Date:11/22/2009)...vember 23, 2009 Agios Pharmaceuticals today annou... first time, that the mutated IDH1 gene has a nove... gene, or oncogene. This breakthrough discovery sh...olite, 2-hydroxyglutarate (2HG), which may contrib...gliomas, the most common type of brain cancers. Th...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4Vocollect and Boston Software Systems Announce Strategic Partnership 57054 1Vocollect and Boston Software Systems Announce Strategic Partnership 57054 2Vocollect and Boston Software Systems Announce Strategic Partnership 57054 3Recent Developments in Transplantation Headline AST Meeting 57050 1Recent Developments in Transplantation Headline AST Meeting 57050 2Bausch 26 Lombs Crystalens 28R 29 to be Featured in Direct to Consumer Advertising 57046 1Bausch 26 Lombs Crystalens 28R 29 to be Featured in Direct to Consumer Advertising 57046 2Bausch 26 Lombs Crystalens 28R 29 to be Featured in Direct to Consumer Advertising 57046 3
...entists at Schepens Eye Research Institute have id...responsible for awakening and putting to sleep bra...m into neurons (nerve cells) and repair damaged br...is week in the Proceedings of the National Academy...ed in the May issue of Stem Cells) by the same sci...
...am has uncovered the likely target of niacin (vita...er picture of how this vitamin helps maintain adeq...lower the risk of heart disease. , While niacin c...w it works has been mysterious, although it,s beli...oduction. Recent work had uncovered that a compone...
...l Society of America (ESA) will hold its 93rd Annu...tration for the meeting is now open to the press. ...udents and educators and will explore the theme, "...nd education." , Prominent environmental biologi... Aug. 3 with his plenary lecture, titled "Ecologic...
Other Biology News: Brain stem cells can be awakened, say Schepens scientists 2Ecological Society of America announces its 93rd Annual Meeting 2Ecological Society of America announces its 93rd Annual Meeting 3
AMAP Multi Site-directed Mutagenesis Kit from MBL International
UCB Eosinophil Chip-IHC from 3H Biomedical AB
Slide Chambers from Novagen
PBMC Cell Chip-IHC from 3H Biomedical AB
Biology Products: